High‐resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure‐based design of ribonucleolytic inhibitors

Protein Science - Tập 12 Số 11 - Trang 2559-2574 - 2003
D.D. Leonidas1, G.B. Chavali2, Nikos G. Oikonomakos3,1, Evangelia D. Chrysina1, Magda Kosmopoulou1, Metaxia Vlassi4, Claire Frankling2, K. Ravi Acharya2
1Institute of Organic and Pharmaceutical Chemistry, The National Hellenic Research Foundation, 11635 Athens, Greece
2Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, UK
3Institute of Biological Research and Biotechnology, The National Hellenic Research Foundation, 11635 Athens, Greece
4Institute of Biology, National Center for Scientific Research “Demokritos”, 15310 Ag. Paraskevi, Athens, Greece

Tóm tắt

AbstractThe crystal structures of bovine pancreatic ribonuclease A (RNase A) in complex with 3′,5′‐ADP, 2′,5′‐ADP, 5′‐ADP, U‐2′‐p and U‐3′‐p have been determined at high resolution. The structures reveal that each inhibitor binds differently in the RNase A active site by anchoring a phosphate group in subsite P1. The most potent inhibitor of all five, 5′‐ADP (Ki = 1.2 μM), adopts a syn conformation (in contrast to 3′,5′‐ADP and 2′,5′‐ADP, which adopt an anti), and it is the β‐ rather than the α‐phosphate group that binds to P1. 3′,5′‐ADP binds with the 5′‐phosphate group in P1 and the adenosine in the B2 pocket. Two different binding modes are observed in the two RNase A molecules of the asymmetric unit for 2′,5′‐ADP. This inhibitor binds with either the 3′ or the 5′ phosphate groups in subsite P1, and in each case, the adenosine binds in two different positions within the B2 subsite. The two uridilyl inhibitors bind similarly with the uridine moiety in the B1 subsite but the placement of a different phosphate group in P1 (2′ versus 3′) has significant implications on their potency against RNase A. Comparative structural analysis of the RNase A, eosinophil‐derived neurotoxin (EDN), eosinophil cationic protein (ECP), and human angiogenin (Ang) complexes with these and other phosphonucleotide inhibitors provides a wealth of information for structure‐based design of inhibitors specific for each RNase. These inhibitors could be developed to therapeutic agents that could control the biological activities of EDN, ECP, and ANG, which play key roles in human pathologies.

Từ khóa


Tài liệu tham khảo

10.1021/ja00778a043

10.1021/bi00845a004

10.1006/jmbi.1999.3093

10.1107/S0907444901021758

10.1021/bi9919145

10.1107/S0567740882008346

10.1038/355472a0

10.1107/S0907444998003254

D'Alessio G., 1997, Ribonucleases: Structure and functions

10.1021/bi00186a001

10.1006/jmbi.1995.0500

10.1016/0014-5793(94)00664-4

10.1093/nar/26.23.5327

10.1086/515322

10.1016/S1093-3263(97)00021-1

10.1021/bi961533g

10.1021/bi00341a030

10.1021/bi980743l

10.1021/bi981369s

Fontecilla‐Camps J.C., 1994, Crystal structure of ribonuclease A•d(ApTpApApG) complex, J. Biol. Chem., 269, 21526, 10.1016/S0021-9258(17)31836-7

10.1107/S0567739478001114

10.1016/B978-012588945-2/50011-X

10.2174/0929866501666220422152935

10.1016/S0065-2776(08)60351-X

10.1016/0022-2836(87)90518-3

10.1107/S0108767389009177

10.1111/j.1432-1033.1983.tb07224.x

10.1021/bi010888j

10.1107/S0108767390010224

10.1107/S0021889891004399

10.1107/S090744499601582X

10.1021/bi9700330

10.1021/bi990900w

10.1074/jbc.M010585200

10.1110/ps.13601

10.1107/S090744499300719X

10.1006/jmbi.1994.1334

10.1016/0022-2836(86)90512-7

Merritt E.A., 1997, Raster3D: Photorealistic molecular graphics, Macromol. Crystallogr., 277, 505

10.1021/bi0264521

10.1093/nar/21.6.1369

10.1107/S0907444996012255

Newton D.L., 1994, Expression and characterization of recombinant human eosinophil‐derived neurotoxin and eosinophil‐derived neurotoxin‐anti‐transferrin receptor sFv, J. Biol. Chem., 269, 26739, 10.1016/S0021-9258(18)47081-0

10.1002/jcc.540120405

10.1016/S0076-6879(97)76066-X

10.1021/cr960427h

10.1097/00002030-200303070-00002

10.1016/S0076-6879(01)41181-5

10.1074/jbc.274.21.14902

10.1006/bbrc.1997.6167

10.1021/bi9800146

10.1021/bi00444a038

10.1021/bi00430a045

Sorrentino S., 1992, Eosinophil‐derived neurotoxin and human liver ribonuclease: Identity of structure and linkage of neurotoxicity to nuclease activity, J. Biol. Chem., 267, 14859, 10.1016/S0021-9258(18)42119-9

10.1021/bi015911f

10.1002/pro.5560050817

10.1021/ja972296n

10.1002/pro.5560031217